Zhongzhi Pharmaceutical Holdings logo

3737 - Zhongzhi Pharmaceutical Holdings News Story

HK$1.4 0.0  0.0%

Last Trade - 7:01am

Consumer Defensives
Small Cap
Market Cap £108.3m
Enterprise Value £96.8m
Revenue £176.2m
Position in Universe 3155th / 6091

BRIEF-Zhongzhi Pharmaceutical Holdings says HY profit attributable rmb38.5 million

Tue 29th August, 2017 12:44pm
Aug 29 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd 
 3737.HK : 
    * HY profit attributable to owners of parent rmb38.5 million 
versus rmb32 million 
    * HY revenue  rmb431.5 million versus rmb359 million a year 
    * Interim dividend of hk1.875 cents per  share 
Source text for Eikon:  ID:nHKSM2lKM  
Further company coverage:  3737.HK  
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.